Catalyst Wire Dossier Catalyst Wire Dossier

Zuretinol Acetate

zuretinol acetate · Retinagenix Holdings
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zuretinol Acetate, covering 2023-02-24 to 2023-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease [Phase 2, Phase 3]

See pricing